Enzyme Defense™ Extra Strength
- Regular price
- $ 73.99
- Sale price
- $ 73.99
- Regular price
-
$ 72.99 - Unit price
- /per
The Benefits
Most Advanced Immune System Support*
Nearly all environmental threats contain proteins that the immune system must identify and break down. Enzymes that break down protein (proteolytic) can support this immune process.*
Enzyme Defense™ Extra Strength is 2x the potency of Enzyme Defense™
- Provides support to purify the body*
- Assists in removing proteins that do not belong in the bloodstream.*
- Naturally help break down excess mucus*
- Promotes healthy circulation*
Usage & Notes
Recommended Use: 1 capsule twice daily on an empty stomach, one hour before or two hours after a meal.
Enzyme Defense is not an “immune stimulator,” rather a supporter of healthy immune function.*
Enzymedica does not use ingredients produced using biotechnology.
Consult with a physician prior to use if pregnant or nursing.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
The Science
Enzyme Defense™ Extra Strength is an improved version of Enzyme Defense. The enhanced formula contains a 60% increase of Serrapeptase (also known as Serratiopeptidase).
Enzymes can break down undigested food protein, cellular debris, and proteins that don’t belong in the bloodstream.*
Oral proteases, taken as a dietary supplement on an empty stomach, are absorbed and carried into the bloodstream where they are bound to plasma proteins known as Alpha-II-macroglobulin.(1)*
Recent research also indicates that the oral proteases bound to these plasma proteins can help break down harmful protein-based invaders in the blood.(2)*
The unique Enzyme Defense formula helps break down protein intruders in the bloodstream.*
- Protease
- Catalase
- Mucolase™
- Serrapeptase
These enzymes exhibit powerful antioxidant properties to help neutralize free radicals, digest mucus, encourage healthy circulation, and support systemic health.*
References
1 Muller, Lauer D. “Modulation of growth factor binding properties of alpha2-macroglubin by enzyme therapy.” Cancer Chemother Pharmacol. 47.Suppl 1 (2001): S4-9
2 Holomanova, Desser L. “Oral therapy with proteolytic enzymes decreases excessive TGF-beta levels in human blood.” Cancer Chemother Pharmacol. 47. Suppl 1 (2001): S10-5
Adding product to your cart
Subscribe today to stay up to date and receive special offers directly in your inbox.
This product is not intended to diagnose, treat, cure, prevent any disease.